Encouraging results of single-dose rabies vaccine
Oxford: A new one-dose rabies vaccine has been found to be effective in protecting against rabies disease, according to preliminary results of a study, with the vaccine safe in phase I clinical trials.
The new vaccine aims to solve problems with current rabies vaccines, including their cost and requiring multiple doses. Researchers say the new rabies vaccine could save thousands of people from the disease each year. Can save from death.
“We are very pleased with these preliminary results, the vaccine performance has been better than we expected,” said Sandy Douglas, associate professor at the University of Oxford and lead researcher on the experiment.
“The problem with current vaccines is that they are expensive and require multiple doses. We are very hopeful that the new vaccine will make routine low-cost and one-dose vaccination possible,” he said.
It should be noted that these vaccine trials were conducted at Oxford University and it happened for the first time that new rabies vaccine trials were conducted on humans.